Start writing here...
Unipharm Healthy Manufacturing of New Zealand has been shortlisted for the Outstanding Business Achievement Award at the 2025 The Hive Awards (Australia). This important nomination from Australia’s food and health manufacturing industry reflects the recognition by international professional bodies of Unipharm’s overall capabilities and long-term development strength.
The Hive Awards
The Hive Awards are organised by Food & Drink Business, an authoritative Australian industry publication, and are among the most influential annual awards in Australia’s food and beverage manufacturing sector. The awards aim to recognise companies that demonstrate sustained value in manufacturing capability, innovation practices, and business performance. Its judging framework spans multiple fields, including health foods, nutritional science, advanced manufacturing, and investment, and is widely regarded for its professionalism and rigour
Among many competing companies, Unipharm’s nomination for the Outstanding Business Achievement Award reflects the company’s demonstrated ability to achieve stable growth over time, the maturity of its manufacturing systems, and its continued commitment to industry development.
Since establishing its manufacturing facility in Auckland in 1979, Unipharm has remained focused on the processing and manufacture of nutritional and health products, continuously strengthening its R&D and production systems while steadily advancing its international footprint. Built around a wide range of nutritional ingredients and dosage forms, the company has developed mature and reliable manufacturing capabilities, supported by strict quality management and an efficient supply chain, providing stable and sustainable product support to global clients.
Being shortlisted for The Hive Awards represents a milestone recognition of Unipharm’s development journey and once again affirms its professional value within the international health manufacturing industry. Looking ahead, the company will continue to focus on manufacturing and R&D fundamentals, further strengthening its capabilities through steady growth, and creating long-term value for the global health industry.
